Reduced incidence of new-onset posttransplantation diabetes mellitus during the last decade

Transplantation

Volumn 84, Issue 9, 2007, Pages 1125-1130

  Valderhaug, Tone Gretland ^a,b,e   Hjelmesæth, Jøran ^a,c   Rollag, Halvor ^a   Leivestad, Torbjørn ^a   Røislien, Jo ^a   Jenssen, Trond ^a,d   Hartmann, Anders ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b Hospital of Buskerud   (Norway)

^c VESTFOLD HOSPITAL TRUST   (Norway)

^d UNIVERSITY OF TROMSØ   (Norway)

^e OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Cytomegalovirus; Immunosuppression; Posttransplantation diabetes mellitus

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; HLA B27 ANTIGEN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS;

ADULT; ARTICLE; BODY MASS; CLINICAL TRIAL; COHORT ANALYSIS; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DIABETES MELLITUS; DIABETIC PATIENT; DRUG DOSE REDUCTION; DRUG DOSE REGIMEN; FEMALE; GRAFT RECIPIENT; GRAFT REJECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; IMPAIRED GLUCOSE TOLERANCE; INCIDENCE; MAJOR CLINICAL STUDY; MALE; ORAL GLUCOSE TOLERANCE TEST; POSTTRANSPLANTATION DIABETES MELLITUS; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

ADULT; AGE DISTRIBUTION; COHORT STUDIES; CYTOMEGALOVIRUS INFECTIONS; DIABETES MELLITUS; GLUCOSE TOLERANCE TEST; HLA-B27 ANTIGEN; HUMANS; KIDNEY TRANSPLANTATION; MIDDLE AGED; PATIENT SELECTION; PHENOTYPE; POSTOPERATIVE COMPLICATIONS;

EID: 36249026353     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000287191.45032.38     Document Type: Article

References (39)

1. Hjelmesæth J. Hartmann A, Leivestad, et al. The impact of early-diagnosed new-onset post transplantation diabetes mellitus on survival and major cardiac events. Kidney Int 2006; 69: 588.
2. Cosio FG, Kudva Y, Van Der Velde M, et al. New onset hyperglycemias and diabetes are associated with increased cardiovascular risk after kidney transplantation. Kidney Int 2005; 67: 2415.
3. Kasiske BL, Snyder JJ, Gilbertson D, Matas AJ. Diabetes mellitus after kidney transplantasjon in the United States. Am J Transplant 2003; 3: 178.
4. Montori VM, Basu A, Erwin PJ, et al. Posttransplantation diabetes mellitus; A systematic review of the literature. Diabetes Care 2002; 25: 583.
5. Hjelmesæth J, Hartmann A, Kofstad J, et al. Glucose intolerance after renal transplantation depends upon prednisolone dose and recipient age. Transplantation 1997; 64: 979.
6. Rodrigo E, Fernández-Fresnedo G, Valero R, et al. New-onset diabetes after kidney transplantation: Risk Factors. J Am Soc Nephrol 2006; 17: 291.
7. Hjelmesæth J, Åsberg A, Müller F, et al. New-onset posttransplantation diabetes mellitus: insulin resistance or insulinopenia? Impact of immunosuppressive drugs, cytomegalovirus and hepatitis C virus infection. Curr Diabetes Rev 2005; 1: 1.
8. Markell M. New-onset diabetes mellitus in transplant patients: Pathogenesis complications, and management. Am J Kid Dis 2004; 43: 954.
9. Hjelmesæth J, Hartmann A, Kofstad J, et al. Tapering off prednisolone and cyclosporin the first year after renal transplantation: The effect on glucose tolerance. Nephrol Dial Transplant 2001; 16: 829.
10. Boots JM, van Duijnhoven EM, Christiaans MH, et al. Glucose metabolisme in renal transplant recipients on tacrolimus: The effect of steroid withdrawal and tacrolimus trough level reduction. J Am Soc Nephrol 2002; 13: 221.
11. Heisel O, Heisel R, Balshaw R, Keown P. New Onset Diabetes Mellitus in patients receiving calcineurin inhibitors: A systematic review and meta-analysis. Am J Transplant 2004; 4: 583.
12. Weir MR, Fink JC. Risk for posttransplant diabetes mellitus with current immunosuppressive medications. Am J Kid Dis 1999; 34: 1.
13. Hjelmesæth J, Hagen LT, Åsberg A, et al. The impact of short-term ciclosporin A treatment on insulin secretion and insulin sensitivity in man. Nephrol Dial Transplant 2007; 22: 1743.
14. Duijnhoven EVM, Christiaans MHL, Boots JMM, et al. Glucose metabolism in the first 3 years after renal transplantation in patients receiving tacrolimus versus cyclosporine-based immunosuppression. J Am Soc Nephrol 2002; 13: 213.
15. Teutonico A, Schena F, Di Paolo S. Glucose metabolism in renal transplant recipients: Effect of calcineurin inhibitor withdrawal and conversion to sirolimus. J Am Soc Nephrol 2005; 16: 3128.
16. Bahtiyar G, Shin JJ, Aytaman A, et al. Association of diabetes and hepatitis C infection: Epidemiologic evidence and pathophysiologic insights. Curr Diabetes Rep 2004; 4: 194.
17. Baid S, Cosimi AB, Farell ML, et al. Posttransplant diabetes mellitus in liver transplant recipients: Risk factors, temporal relationship, with hepatitis C virus allograft hepatitis, and impact on mortality. Transplantation 2001; 72: 1066.
18. Bloom RD, RAO V, Weng F, et al. Association of Hepatitis C with posttransplant diabetes in renal transplant patients on tacrolimus. J Am Soc Nephrol 2002; 13: 1374.
19. Sens YA, Silva VD, Malafronte P, et al. Posttransplant diabetes mellitus in renal transplant patients with hepatitis C virus. Transplant Proc 2004; 36: 886.
20. Gentil MA, Luna E, Rodriguez-Algarra G, et al. Incidence of diabetes mellitus requiring insulin treatment after renal transplantation in patients with hepatitis C. Nephrol Dial Transplant 2002; 17: 887.
21. Hjelmesæth J, Sagedal S, Hartmann A, et al. Asymptomatic CMV infection is associated with increased risk of new onset diabetes mellitus and impaired insulin release after renal transplantation. Diabetologia 2004; 47: 1500.
22. Hjelmesæth J, Midtvedt K, Jenssen T, Hartmann A. Insulin resistance after renal transplantation; Impact of immunosuppressive and antihypertensive therapy. Diabetes Care 2001; 24: 2121.
23. Hjelmesæth J, Jenssen T, Hagen M, et al. Determinants of insulin secretion after renal transplantation. Metabolism 2003; 52: 573.
24. Davidson J, Wilkinson A, Dantal J, et al. Diabetes after transplantation: 2003 international consensus guidelines. Transplantation 2003; 75: 3.
25. Davidson J, Wilkinson A, Dantal J. New-onset diabetes after transplantation: 2003 international consensus guidelines. An endocrinologist's view. Diabetes Care 2004; 27: 805.
26. Definition, diagnosis and classification of diabetes mellitus and its complications: report of a WHO consultation. Part 1: Diagnosis and Classification of Diabetes Mellitus. Geneva: World Health Organization, 1999.
27. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2006; 29: 43.
28. Armstrong KA, Prins JB, Beller EM, et al. Should an oral glucose tolerance test be performed routinely in all renal transplant recipients? Clin J Am Soc Nephrol 2006; 1: 100.
29. Vartdal F, Gaudernack G, Funderud S, et al. HLA class II and II typing using cells positively selected from blood by immunomagnetic isolation: A fast and reliable technique. Tissue Antigens 1986; 28: 301.
30. Sagedal S, Nordal KP, Hartmann A, et al. A prospective study of the natural course of cytomegalovirus infection in renal allograft recipients. Transplantation 2000; 27: 1166.
31. World Medical Association Declaration of Helsinki: Recommendations guiding physicians in biomedical research involving human subjects. JAMA 1997; 277: 925.
32. Cosio FG, Pesavento TE, Osei K, et al. Post-transplant diabetes mellitus: Increasing incidence in renal allograft recipients transplanted in recent years. Kidney Int 2001; 59: 732.
33. Maes BD, Kupyers D, Messiaen T, et al. Posttransplantation diabetes mellitus in FK-506-treated renal transplant recipients: Analysis of incidence and risk factors. Transplantation 2001; 72: 1655.
34. Greenberg AS, McDaniel ML. Identifying the links between obesity, insulin resistance and beta-cell function: potential role of adipocyte-derived cytokines in the pathogenesis of type 2 diabetes. Eur J Clin Invest 2002; 32: 24.
35. Nordøy I, Muller F, Nordal KP, et al. The role of the tumor necrosis factor system and interleukin-10 during cytomegalovirus infection in renal transplant recipients. J Infect Dis 2000; 181: 51.
36. Hjelmesæth J, Müller F, Jenssen T, et al. Is there a link between cytomegalovirus infection and new-onset posttransplantation diabetes mellitus? Potential mechanisms of virus induced beta cell damage. Nephrol Dial Transplant 2005; 20: 2311.
37. Rollag H, Sagedal S, Kristiansen KI, et al. Cytomegaovirus DNA concentration in plasma predicts development of cytomegalovirus disease in kidney transplant recipients. Clin Microbiol Infection 2002; 8: 431.
38. Barr RG, Nathan M, Meigs JB, Singer DE. Tests of glycemia for the diagnosis of type 2 diabetes mellitus. Ann Intern Med 2002; 137: 263.
39. Sharif A, Moore RH, Baboolal. The use of oral glucose tolerance test to risk stratify for new-onset diabetes after transplantation: An underdiagnosed phenomenon. Transplantation 2006; 82: 1667.